Table 3. Relationships between TAGLN2 expression and clinicopathological factors in tissue microarray.
|
TAGLN2 expression (score)
|
|||||
|---|---|---|---|---|---|
| Characteristics | n | Low (0–2) | Moderate (3 to 4) | High (5 to 6) | P-values |
| Normal and BC tissue | |||||
| Normal | 8 | 8 | 0 | 0 | 0.0202 |
| Cancer | 47 | 22 | 20 | 5 | |
| Age at presentation | |||||
| >65 years | 17 | 9 | 6 | 2 | 0.7499 |
| ⩽65 years | 30 | 13 | 14 | 3 | |
| Sex | |||||
| Male | 38 | 17 | 18 | 3 | 0.2635 |
| Female | 9 | 5 | 2 | 2 | |
| Histological grade | |||||
| G1+G2 | 28 | 14 | 14 | 0 | 0.0148 |
| G3 | 19 | 6 | 8 | 5 | |
| Tumour status | |||||
| T1 | 10 | 5 | 4 | 1 | 0.9536 |
| T2+T3+T4 | 28 | 15 | 11 | 2 | |
| Unknown | 9 | ||||
| LN metastasis | |||||
| N0 | 40 | 50 | 17 | 3 | 0.5195 |
| N1 | 1 | 0 | 1 | 0 | |
| Unknown | 6 | ||||
| Distant metastasis | |||||
| M0 | 43 | 22 | 18 | 3 | 0.0145 |
| M1 | 4 | 0 | 2 | 2 | |
Abbreviations: TAGLN2=transgelin 2; BC=bladder cancer; LN=lymph node.